Gunaldi, M. Et Al. 2016. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2 , 242-247.

Gunaldi, M., Duman, B. B., Afsar, C. U., PAYDAŞ, S., Erkisi, M., KARA, İ. O., ... ŞAHİN, B.(2016). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 242-247.

Gunaldi, Meral Et Al. "Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 242-247, 2016

Gunaldi, Meral Et Al. "Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.242-247, 2016

Gunaldi, M. Et Al. (2016) . "Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.242-247.

@article{article, author={Meral Gunaldi Et Al. }, title={Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2016, pages={242-247} }